Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection

Tess Karre, Lynne Sloan, Robin Patel, Jayawant Mandrekar, Jon Rosenblatt

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

We compared two commercial PCR assays, the Prodesse ProGastro CD assay and the BD GeneOhm Cdiff assay, with a laboratory-developed Clostridium difficile toxin PCR assay with previously established performance characteristics. Results of all methods were in agreement for 333 (96%) of 346 stool specimens. No significant difference in performance among the assays was found (P values, >0.05).

Original languageEnglish (US)
Pages (from-to)725-727
Number of pages3
JournalJournal of clinical microbiology
Volume49
Issue number2
DOIs
StatePublished - Feb 1 2011

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection'. Together they form a unique fingerprint.

  • Cite this